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Summary Serum retinol levels were determined by a fluorometric method in patients with colorectal cancer
or polyps and those with inflammatory bowel disease. Serum retinol levels in patients with benign or
malignant colorectal polyps and stage B cancer (modified Dukes' classification) were similar to those found in
controls. By contrast, serum retinol levels were significantly lower in patients with Dukes' stage C or D.
Among cancer patients that were followed after surgical treatment serum retinol levels did not differ
significantly from those found in controls. Patients who died of metastases during follow-up possessed very
low serum retinol levels. These findings suggest that a decreased serum retinol level in cancer patients is a
consequence rather than a precursor of the neoplastic process. Furthermore, this study suggests that the
marked decrease in serum retinol level might be an indicator of poor prognosis in colorectal cancer patients
after surgery.
While vitamin A and its derivatives may play an important
role in experimental carcinogenesis (Goodman, 1980; Sporn
& Roberts, 1983), much less is known about the relationship
between vitamin A and cancer in man. The bulk of evidence
to support the existence of such a relation derives from
studies on dietary habits and cancer incidence (Bjelke, 1975;
Mettlin et al., 1979) and from those of retinol levels in sera
of cancer patients (Wald et al., 1980; Kark et al., 1981).
Initial studies suggested that low serum retinol levels might
indicate an increased risk of developing cancer. However,
more recent studies failed to confirm an inverse association
between serum retinol level and overall cancer incidence
(Willet et al., 1984; Peleg et al., 1984).
Our previous study (Sawicki et al., 1985) and those of
others (Atukorala et al., 1979; Ibrahim et al., 1977) showed
that serum retinol levels were lower in colorectal cancer
patients than in healthy controls. The decreased retinol level
in cancer patients can be a primary or secondary
phenomenon, for example, a result of decreased intestinal
absorption or of impaired release of vitamin A from liver
storage. An alternative explanation might be that decreased
serum retinol level is associated with host metabolic changes
induced by the neoplastic process. If this were true, one
might expect a negative correlation between serum retinol
level and tumour burden. The purpose of this study was to
test this latter hypothesis by determining serum retinol level
in patients with benign or malignant colonic polyps and in
those with colorectal cancers of differing stage.
Materials and methods
Three hundred and twenty subjects, assigned to 5 groups,
were studied.
1. Patients with colrectal cancer (n=84, 31 females and 53
males; aged 39-76 years) in whom the diagnosis was
confirmed by histologic examination: Sixty-eight of
these were treated surgically and staging of
adenocarcinoma was established according to the
modified Dukes' classification (Nowacki & Szymendera,
1983).
2. Patients with malignant colonic polyps (n =23, 10
females and 13 males; aged 39-78 years) that were
removed colonoscopically or surgically: The histologic
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examination of all these polyps showed an
adenomatous structure and evidence of malignant
change (invasion of muscularis mucosae).
3. Patients with benign colonic polyps (n=72, 32 females
and 40 males; aged 26-83 years): Sixty-eight had one or
more polyps classified as tubular, tubulovillous, or
villous adenomas and the remaining 4 patients had
familial polyposis coli.
4. Patients with inflammatory bowel disease (n=34, 19
females and 15 males; aged 18-56 years): Twenty-three
had ulcerative colitis and 11, Crohn's disease.
5. Control patients (n = 107, 41 females and 66 males;
aged 38-80 years) were selected from patients referred
to the Department of Gastroenterology and were
matched with cancer and malignant polyps for age, sex,
and social position. They had no symptoms of liver
disease or other pathologic conditions known to
influence serum retinol level. This group consisted of
patients with various gastrointestinal disorders such as
gastric or duodenal ulcer, irritable bowel syndrome, and
diverticular disease of the colon.
Sera were collected from patients on their admission to
hospital in tubes protected from light and were kept frozen
until use for no longer than 2 weeks. Eighteen cancer
patients treated surgically were observed for a period from 1
month to 2.5 years postoperatively and blood samples were
obtained three times during this term. The period intervals
from the date of surgery to the date of serum collection
were: 1-3 months, 4-12 months, and over 12 months after
surgical treatment.
Serum retinol levels were determined by the fluorometric
method of Thompson et al. (1971). All methodological
procedures were performed in moderate yellow light.
Student's paired and unpaired t-tests were used for
conventional statistical analyses of differences between
groups and P values <0.05 were considered as probably
significant and P<0.01 as statistically significant. Each value
was expressed as mean+s.e.
Results
Table I presents serum retinol levels in the various patients
groups. In 107 control patients serum retinol levels ranged
from 31.2 to 89.3pg I00ml 1 with a mean of 57.3. It can be
seen that only patients with colorectal cancer and those with
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Table I Serum retinol levels (g 100ml-1) in test groups and
controls
Patient groups Serum retinol level
(number) (mean+s.e.)
Controls (107) 57.3+ 1.9
Colorectal cancer (84) 43.1 +2.7a
Colonic adenoma (72) 53.1 + 1.6
Malignant polyps (23) 61.2+ 3.1
Inflammatory bowel disease (34) 39.7+4.5a
aSignificance of difference from controls, P<0.01 (Student's t test).
Table II Serum retinol levels (g 100m1-1) in
colorectal cancer patients divided according to
modified Dukes' classification
Serum retinol level
Stage (number ofpatients) (mean+s.e.)
B (26) 52.3 +3.7
C (20) 42.8+4.3a
D (22) 43.7+3.7a
aSignificance of difference from controls P<0.01
(see Table I).
Table III Serum retinol levels (pg1OOm1-m ) in 18 colorectal
cancer patients observed after surgical treatment
Post-surgery
Follow-up period (months)
Pre-surgery 1-3 4-12 12
45.4+2.1 49.8+2.3a 53.1 +2.7b 53.6+ 1.8b
aSignificance of difference from pre-surgery values, P<0.05.
bSignificance of difference from pre-surgery value, P<0.01.
inflammatory bowel disease had significantly decreased mean
serum retinol levels compared to control patients (P<0.01).
The patients with benign or malignant colonic polyps had
serum retinol levels which did not differ from those of
controls.
Table II shows retinol levels in the sera of colorectal
cancer patients that were divided according to the modified
Dukes' classification. Serum retinol levels were significantly
decreased only in patients with disease stage C or D
(P<0.01).
Serum retinol levels in 18 cancer patients before and in
three period intervals after surgery are shown in Table III.
Before surgery, the cancer patients had decreased mean
serum retinol level compared to controls (P<0.01), whereas
after surgery they had almost normal levels regardless of the
length of follow-up. Their serum retinol levels determined
1-3 months after surgery were probably significantly higher
than levels before surgery (P<0.05), and in further- follow-up
periods were significantly higher (P<0.01) using the paired
t-test.
A distinctive group comprised 21 previously treated
patients who died of metastases during the follow-up period.
Their retinol levels determined 3-6 months after surgery
(3-20 months before death) were very low both in those with
synchronous (9 patients) and metachronous (12 patients)
metastases (42.6 and 37.0jg 100ml- 1, respectively).
Discussion
Our study revealed significantly lower retinol levels in the
sera of colorectal cancer patients and those with
inflammatory bowel disease, than of controls. The retinol
levels were similar in patients with benign or malignant
colorectal polyps and did not differ from those found in
controls. When colorectal cancer patients were divided
according to Dukes' classification, those with stage B
tumours had almost normal retinol levels, whereas those
with C or D stage tumours had significantly lower levels
compared to control patients. These data suggest that there
is a negative correlation between the degree of advancement
of colorectal cancer and serum retinol level. Consequently,
the decreased serum retinol level may be a secondary rather
than a primary phenomenon in cancer patients, possibly
induced by the tumour itself. Further support for such a
hypothesis is provided by the results obtained in our treated
patients in whom the mean serum retinol levels estimated
postoperatively did not differ from those obtained in
controls.
Our results are different from those obtained by Basu et
al. (1985) who reported low serum retinol levels in their
postoperative patients, who were otherwise free of disease.
Among our postoperative patients, serum retinol levels were
decreased only in those who died of metastases during
follow-up. In the remaining colorectal cancer patients who
appeared to be disease-free, serum retinol levels significantly
increased to control values. All of the latter patients had
normal calorific nutrition in the postoperative period as
judged by dietary interview. An improvement in the
nutritional state was observed during follow-up. However,
there was no correlation between their serum retinol level
and body weight.
It is difflcult to explain the difference between the two
studies; one possibility is that serum storage time may
influence the determination of retinol levels. In our study
sera were not stored longer than two weeks.
In patients with inflammatory bowel disease, serum retinol
levels correlated with clinical activity of the disease to the
extent that the lowest values were found in patients with
very active disease. These findings confirmed earlier results
of others for patients with Crohn's disease (Main, 1983;
Schoelmerich, 1985). Furthermore, low serum retinol levels
were found in patients with chronic pancreatitis or
cholecystitis and in those with acute febrile illnesses
(unpublished data). Since retinol binding protein has a
relatively short half-life, its synthesis is sensitive to protein
and/or energy deprivation, causing a decrease in serum
retinol level. It seems, therefore, that the majority of our
patients with low serum retinol level had impairment of
protein energy balance similar to that in hunger and post-
aggression metabolism.
In conclusion, our results indicate that decreased serum
retinol levels in colorectal cancer patients is secondary to the
disease rather than vice versa. The mechanism of this
decrease is, as yet, unknown. It can only be speculated that
low retinol levels in the sera of colorectal cancer patients
results from an interaction of an enlarging tumour mass and
a host factor(s) such as increased protein catabolism or
inflammation.- Furthermore, this study suggests that a
dramatic decrease in serum retinol level in the postoperative
period can be an indicator of a poor prognosis in patients
with colorectal cancer.
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